Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis
Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis
Kurinchi Selvan Gurusamy
1, 2
, PhD ;
Christian Gluud
2, 3, 4
, MD, Dr Med Sci
1
Division of Surgery and Interventional Science, University College London, London, United Kingdom
2
Cochrane Hepato-Biliary Group, Copenhagen, Denmark
3
The Copenhagen Trial Unit, Copenhagen, Denmark
4
Department of Regional Health Research, Odense, Denmark
Corresponding Author:
-
Kurinchi Selvan Gurusamy, PhD
-
Division of Surgery and Interventional Science
-
University College London
-
9th Floor, Royal Free Hospital, Royal Free Campus (Hampstead Campus)
-
Rowland Hill Street
-
London NW3 2PF
-
United Kingdom
-
Phone:
44 02080168116
-
Email: k.gurusamy@ucl.ac.uk